|
|
|
Volumn 22, Issue 2, 1997, Pages 86-92
|
|
Fluticasone: Pharmacology and efficacy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
BUDESONIDE;
CORTICOSTEROID;
FLUNISOLIDE;
FLUTICASONE;
FLUTICASONE PROPIONATE;
GLUCOCORTICOID;
GLUCOCORTICOID RECEPTOR;
PLACEBO;
PREDNISONE;
SALBUTAMOL;
THEOPHYLLINE;
TRIAMCINOLONE;
ADOLESCENT;
ADRENAL INSUFFICIENCY;
ADULT;
ASTHMA;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DYSPHONIA;
FEMALE;
FORCED EXPIRATORY VOLUME;
HEADACHE;
HOARSENESS;
HUMAN;
HYDROCORTISONE BLOOD LEVEL;
INHALATIONAL DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
NOSE CONGESTION;
ORAL DRUG ADMINISTRATION;
PATIENT MONITORING;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
THRUSH;
TREATMENT INDICATION;
TREATMENT OUTCOME;
UPPER RESPIRATORY TRACT INFECTION;
|
|
EID: 0030894655
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (14)
|
